Matinas BioPharma Holdings, Inc. (MTNB): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-50, first reflected in a filing dated 2024-11-13. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

6.41M
As of 2025-12-31
6.41M
As of 2026-06-30
217.26M2013-12-31: 32.00M2014-12-31: 32.29M2015-12-31: 57.18M2016-12-31: 58.16M2017-12-31: 93.37M2018-12-31: 113.29M2019-12-31: 163.16M2020-12-31: 200.11M2021-12-31: 216.27M2022-12-31: 217.26M2023-12-31: 4.35M2024-12-31: 5.09M2025-12-31: 6.41M6.41M
2013-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-316.41M+25.9%2026-03-31, Balance as of period end
2024-12-315.09M+17.1%2026-03-31, Balance as of period end
2023-12-314.35Mn/c2025-04-15, Balance as of period end
2022-12-31217.26M+0.5%2024-03-27, Balance as of period end
2021-12-31216.27M+8.1%2023-03-15, Balance as of period end
2020-12-31200.11M+22.7%2022-03-11, Balance as of period end
2019-12-31163.16Mn/c2021-03-29, Balance as of period end
2018-12-31113.29M+21.3%2020-03-09, Balance as of period end
2017-12-3193.37M+60.5%2019-04-01, Balance as of period end
2016-12-3158.16M+1.7%2018-03-16, Balance as of period end
2015-12-3157.18M+77.1%2017-03-31, Balance as of period end
2014-12-3132.29M+0.9%2016-03-30, Balance as of period end
2013-12-3132.00Mn/a2015-03-31, Balance as of period end